Telix Pharmaceutical share price down after bond raise completion
MELBOURNE: Telix Pharmaceuticals shares are down nearly 3 per cent to $19.22 close to noon
MELBOURNE: Telix Pharmaceuticals shares are down nearly 3 per cent to $19.22 close to noon
FEATURED
Assisted living providers learn strategies to tackle staffing challenges
Senior living operators plan more moderate rental rate growth in 2026
Former city mortuary is now taking new senior residents
Best affordable housing design for Global Awards shortlisted
Planning authorities take wrecking ball to boomer projects
Best social housing community design for Global Awards shortlisted
INNOVATION
